Tailored gene therapy could replace drugs for HIV patients

| February 4, 2013 |

The following is an excerpt.

One of the biggest problems in treating HIV patients is the amount of daily individual medications it takes to keep the virus at bay. In a new study, scientists at the Stanford University School of Medicine have engineered a new approach to tailored gene therapy that they say makes key cells of the immune system resistant to attack from the HIV virus, which may eventually lead to the removal of life-long dependencies on drugs for patients living with HIV.

View the original article here: Tailored gene therapy approach could replace drug treatments for HIV patients